| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.99B | 34.72B | 36.73B | -2.69B | 64.45B | 60.60B |
| Gross Profit | 12.00B | 13.39B | 11.12B | 11.06B | 12.93B | 11.22B |
| EBITDA | 5.64B | 5.93B | 3.98B | 4.96B | 4.72B | 3.80B |
| Net Income | 4.17B | 4.07B | 2.87B | 3.73B | 3.26B | 3.08B |
Balance Sheet | ||||||
| Total Assets | 858.68B | 802.16B | 713.23B | 701.46B | 630.49B | 600.49B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 24.71B | 19.38B | 18.84B | 17.23B | 7.95B |
| Total Debt | 10.24B | 10.23B | 9.65B | 11.29B | 9.73B | 10.71B |
| Total Liabilities | 826.96B | 771.01B | 683.38B | 669.14B | 600.00B | 573.48B |
| Stockholders Equity | 28.56B | 29.54B | 26.84B | 29.01B | 27.22B | 24.03B |
Cash Flow | ||||||
| Free Cash Flow | 5.02B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B |
| Operating Cash Flow | 5.02B | 4.75B | 5.20B | 7.05B | 10.37B | 9.61B |
| Investing Cash Flow | -20.00M | -408.00M | -786.00M | -5.49B | -11.21B | -8.20B |
| Financing Cash Flow | -3.45B | -2.29B | -3.55B | -620.00M | -992.00M | 2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | C$83.31B | 15.74 | 11.23% | 3.58% | 5.46% | 10.52% | |
79 Outperform | $58.52B | 8.24 | 18.65% | 0.87% | 10.08% | 24.18% | |
76 Outperform | C$61.43B | 15.56 | 15.09% | 3.67% | -20.64% | 14.88% | |
76 Outperform | C$46.13B | 15.13 | 13.24% | 3.33% | -9.03% | 44.14% | |
73 Outperform | C$50.01B | 16.77 | 16.27% | 1.89% | 2.51% | 44.44% | |
68 Neutral | C$46.95B | 15.97 | 11.96% | 4.17% | -19.88% | -13.92% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
Great-West Lifeco Inc. announced the dividend rates for its Non-Cumulative 5-Year Rate Reset First Preferred Shares, Series N, and Non-Cumulative Floating Rate First Preferred Shares, Series O. The fixed dividend rate for Series N Shares is set at 4.090% per annum for the five-year period starting December 31, 2025, while the floating rate for Series O Shares is 3.518% per annum for the period starting on the same date. This announcement provides clarity on the financial returns for investors holding these shares and underscores the company’s commitment to offering competitive financial products, potentially impacting its market positioning and attractiveness to investors.
Great-West Lifeco announced that it will not redeem its Non-Cumulative 5-Year Rate Reset First Preferred Shares, Series N, on December 31, 2025. Instead, holders of these shares have the option to convert them into Non-Cumulative Floating Rate First Preferred Shares, Series O, subject to certain conditions. This decision provides shareholders with flexibility in managing their investments, potentially impacting the company’s financial structuring and market positioning.
Great-West Lifeco Inc. reported significant financial growth in Q3 2025, with base earnings rising by 15% to $1.23 billion and net earnings increasing by 35% to $1.16 billion compared to the previous year. This performance was driven by strong growth in its U.S., Europe, and Capital and Risk Solutions businesses, supported by favorable market conditions and strategic business transformations. The company plans to increase share buybacks to $1.5 billion for the year, highlighting its robust capital generation and financial flexibility.
Great-West Lifeco Inc. will release its third quarter 2025 financial results after market close on November 5, with a conference call scheduled for November 6 to discuss the results. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic positioning in the financial services industry.
Great-West Lifeco has successfully completed its offering of 8 million Series Z Preferred Shares, raising $200 million in gross proceeds. The shares, which will trade on the Toronto Stock Exchange under the symbol GWO.PR.Z, were offered through a syndicate of underwriters led by BMO Capital Markets, RBC Capital Markets, and Scotiabank. This move is expected to strengthen Great-West Lifeco’s financial position and enhance its market presence.
Great-West Lifeco announced an agreement with a syndicate of underwriters to issue 6,000,000 Non-Cumulative First Preferred Shares, Series Z, at C$25.00 per share, raising C$150 million. The offering, which may increase to C$200 million if an option to purchase additional shares is exercised, is intended for general corporate purposes and is expected to close on or about September 24, 2025. This move is part of Lifeco’s strategy to strengthen its financial position and enhance its market presence in the financial services industry.
Great-West Lifeco Inc. announced that Edmund F. Murphy, President and CEO of Empower, will participate in a virtual fireside chat with TD Cowen’s Senior Equity Analyst, William Katz, on September 15, 2025. This event highlights the company’s engagement with financial analysts and stakeholders, potentially impacting its market visibility and investor relations.